These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 6419679)

  • 1. Failure of lysine in frequently recurrent herpes simplex infection. Treatment and prophylaxis.
    DiGiovanna JJ; Blank H
    Arch Dermatol; 1984 Jan; 120(1):48-51. PubMed ID: 6419679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Success of L-lysine therapy in frequently recurrent herpes simplex infection. Treatment and prophylaxis.
    Griffith RS; Walsh DE; Myrmel KH; Thompson RW; Behforooz A
    Dermatologica; 1987; 175(4):183-90. PubMed ID: 3115841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysine prophylaxis in recurrent herpes simplex labialis: a double-blind, controlled crossover study.
    Milman N; Scheibel J; Jessen O
    Acta Derm Venereol; 1980; 60(1):85-7. PubMed ID: 6153847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of lysine in frequently recurrent herpes simplex infection.
    Simon CA; Van Melle GD; Ramelet AA
    Arch Dermatol; 1985 Feb; 121(2):167-8. PubMed ID: 3919651
    [No Abstract]   [Full Text] [Related]  

  • 5. [Oral acyclovir therapy in recurrent herpes simplex].
    Djawari D
    Z Hautkr; 1986 Nov; 61(22):1629-32, 1637. PubMed ID: 3811459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effect of 1,5-pentanediol for herpes simplex labialis: a randomized, double-blind, placebo-controlled clinical trial.
    Busch R; Graubaum HJ; Gruenwald J; Faergemann J
    Adv Ther; 2009 Jul; 26(7):719-27. PubMed ID: 19649583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lysine prevention in recurrent labial herpes simplex].
    Milman N; Scheibel J; Jessen O
    Ugeskr Laeger; 1980 May; 142(19):1202-3. PubMed ID: 6773197
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lysine therapy of recurrent herpes simplex labialis].
    Milman N; Jessen O; Scheibel J
    Ugeskr Laeger; 1979 Oct; 141(43):2960-2. PubMed ID: 392853
    [No Abstract]   [Full Text] [Related]  

  • 9. An update on short-course intermittent and prevention therapies for herpes labialis.
    Gilbert S; Corey L; Cunningham A; Malkin JE; Stanberry L; Whitley R; Spruance S
    Herpes; 2007 Jun; 14 Suppl 1():13A-18A. PubMed ID: 17877887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced rate of recurrent genital herpes infections with lithium carbonate.
    Amsterdam JD; Maislin G; Potter L; Giuntoli R
    Psychopharmacol Bull; 1990; 26(3):343-7. PubMed ID: 2125737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balm mint extract (Lo-701) for topical treatment of recurring herpes labialis.
    Koytchev R; Alken RG; Dundarov S
    Phytomedicine; 1999 Oct; 6(4):225-30. PubMed ID: 10589440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection.
    Wald A; Carrell D; Remington M; Kexel E; Zeh J; Corey L
    Clin Infect Dis; 2002 Apr; 34(7):944-8. PubMed ID: 11880960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subjective response to lysine in the therapy of herpes simplex.
    Walsh DE; Griffith RS; Behforooz A
    J Antimicrob Chemother; 1983 Nov; 12(5):489-96. PubMed ID: 6423612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ineffectiveness of topical adenine arabinoside 5'-monophosphate in the treatment of recurrent herpes simplex labialis.
    Spruance SL; Crumpacker CS; Haines H; Bader C; Mehr K; MacCalman J; Schnipper LE; Klauber MR; Overall JC
    N Engl J Med; 1979 May; 300(21):1180-4. PubMed ID: 86158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Beta-interferon for labial and genital herpes virus infection].
    Glezerman M; Lunenfeld E; Doerner T; Cohen V; Sarov I; Revel M
    Harefuah; 1989 Jan; 116(2):88-90. PubMed ID: 2651244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of oral inosiplex treatment of recurrent herpes simplex virus infections.
    Kalimo KO; Joronen IA; Havu VK
    Arch Dermatol; 1983 Jun; 119(6):463-7. PubMed ID: 6190441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of recurrent herpes simplex infections with L-lysine monohydrochloride.
    McCune MA; Perry HO; Muller SA; O'Fallon WM
    Cutis; 1984 Oct; 34(4):366-73. PubMed ID: 6435961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
    Fife KH; Warren TJ; Justus SE; Heitman CK;
    Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial.
    Sacks SL; Thisted RA; Jones TM; Barbarash RA; Mikolich DJ; Ruoff GE; Jorizzo JL; Gunnill LB; Katz DH; Khalil MH; Morrow PR; Yakatan GJ; Pope LE; Berg JE;
    J Am Acad Dermatol; 2001 Aug; 45(2):222-30. PubMed ID: 11464183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group.
    Spruance SL; Tyring SK; DeGregorio B; Miller C; Beutner K
    Arch Intern Med; 1996 Aug 12-26; 156(15):1729-35. PubMed ID: 8694673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.